Description

[7-(3-Ethyl-1,2,4-Oxadiazol-5-Yl)[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl]Aceticacid is a high-purity, advanced pharmaceutical intermediate characterized by its complex fused heterocyclic structure. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. It is primarily sought by research institutions and pharmaceutical manufacturers engaged in drug discovery and development programs, especially those focusing on central nervous system (CNS) and oncology targets.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates, particularly those with triazolo-pyridine and oxadiazole pharmacophores.
• Drug Discovery Research: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization in academic and industrial R&D labs.
• API Synthesis: Incorporated into the final molecular structure of potential Active Pharmaceutical Ingredients (APIs) targeting specific biological pathways.
• Biochemical Tool Compound: May be utilized in biochemical assays to study enzyme inhibition or receptor binding mechanisms.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects under cGMP conditions.

Basic Information

Product Name	[7-(3-Ethyl-1,2,4-Oxadiazol-5-Yl)[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl]Aceticacid
CAS No.	1338682-10-2
Molecular Formula	C₁₂H₁₀N₆O₃
Molecular Weight	286.25 g/mol
Synonyms	2-{7-[(3-Ethyl-1,2,4-oxadiazol-5-yl)][1,2,4]triazolo[4,3-a]pyridin-3-yl}acetic acid; [7-(3-Ethyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetic acid; 1338682-10-2; 7-(3-Ethyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-ylacetic acid; Acetic acid, 2-[7-(3-ethyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]-
EINECS	Contact for details

Quality Control

Our production of [7-(3-Ethyl-1,2,4-Oxadiazol-5-Yl)[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl]Aceticacid adheres to stringent quality protocols to ensure batch-to-batch consistency and purity suitable for advanced research and pharmaceutical development. All materials are characterized by advanced analytical techniques including HPLC, NMR, and MS. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment. We support development under quality systems aligned with cGMP guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed in a dry environment to protect the compound from moisture. For long-term storage, consider inert gas purging.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.